Changes to Products. Bioject shall make changes to the Products reasonably requested by Serono, provided that Serono shall pay the cost of engineering any change to Products requested by it. Bioject shall promptly provide Serono with an estimate of such costs and receive Serono's approval of such estimate before undertaking any change to the Products. Bioject shall not make any other changes to the Products without Serono's prior written approval, which shall not be unreasonably withheld or delayed. Serono may withhold its approval in all cases where the requested change would impact its regulatory commitments or approvals with respect to human growth hormone or delivery of human growth hormone using the Products.
Appears in 3 contracts
Sources: License and Distribution Agreement (Bioject Medical Technologies Inc), License and Distribution Agreement (Bioject Medical Technologies Inc), License and Distribution Agreement (Bioject Medical Technologies Inc)